PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 172 filers reported holding PRECIGEN INC in Q2 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $264,000 | +1452.9% | 186,035 | +1155.7% | 0.00% | – |
| Q2 2023 | $17,000 | +70.0% | 14,815 | +66.6% | 0.00% | – |
| Q1 2023 | $10,000 | -44.4% | 8,890 | -25.9% | 0.00% | – |
| Q4 2022 | $18,000 | +157.1% | 11,996 | +258.0% | 0.00% | – |
| Q3 2022 | $7,000 | +75.0% | 3,351 | +12.2% | 0.00% | – |
| Q2 2022 | $4,000 | -83.3% | 2,987 | -74.7% | 0.00% | – |
| Q1 2022 | $24,000 | -89.6% | 11,789 | -81.0% | 0.00% | – |
| Q4 2021 | $230,000 | -27.7% | 62,073 | -2.3% | 0.00% | – |
| Q3 2021 | $318,000 | +95.1% | 63,546 | +154.1% | 0.00% | – |
| Q2 2021 | $163,000 | -0.6% | 25,011 | +5.4% | 0.00% | – |
| Q1 2021 | $164,000 | -13.7% | 23,738 | +27.0% | 0.00% | – |
| Q4 2020 | $190,000 | +171.4% | 18,692 | -6.1% | 0.00% | – |
| Q3 2020 | $70,000 | -27.1% | 19,898 | +3.2% | 0.00% | – |
| Q2 2020 | $96,000 | -39.2% | 19,286 | -58.4% | 0.00% | – |
| Q1 2020 | $158,000 | – | 46,315 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |